A multiplexed, confinable CRISPR/Cas9 gene drive can propagate in caged Aedes aegypti populations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38272895.
- Also identified by DOI 10.1038/s41467-024-44956-2 and PMC identifier 10810878.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Aedes aegypti is the main vector of several major pathogens including dengue, Zika and chikungunya viruses. Classical mosquito control strategies utilizing insecticides are threatened by rising resistance. This has stimulated interest in new genetic systems such as gene drivesHere, we test the regulatory sequences from the Ae. aegypti benign gonial cell neoplasm (bgcn) homolog to express Cas9 and a separate multiplexing sgRNA-expressing cassette inserted into the Ae. aegypti kynurenine 3-monooxygenase (kmo) gene. When combined, these two elements provide highly effective germline cutting at the kmo locus and act as a gene drive. Our target genetic element drives through a cage trial population such that carrier frequency of the element increases from 50% to up to 89% of the population despite significant fitness costs to kmo insertions. Deep sequencing suggests that the multiplexing design could mitigate resistance allele formation in our gene drive system.
Medical subject headings
- Aedes
- Gene Drive Technology
- Insecticides
- Zika Virus Infection
- Zika Virus